Skip to main content

Table 1 Patients’ baseline demographic and clinical characteristic

From: The homing of bone marrow stem cells is differentially activated in ischemic and valvular heart diseases and influenced by beta-blockers

Characteristics

IHD (n = 41)

VHD (n = 29)

P

Age (years)

57.95 ± 7.57

58.52 ± 11.09

0.800

Male (%)

35 (85.4)

20 (69.0)

0.177

Cardiovascular risk factors and comorbidities (%)

 Hypertension

35 (85.4)

22 (76.8)

0.487

 Smoking

19 (46.3)

9 (31.0)

0.298

 Diabetes mellitus

17 (41.4)

12 (41.3)

1.000

 Dyslipidemia

13 (31.7)

5 (17.2)

0.277

 Heart failure

6 (14.6)

8 (27.5)

0.302

 Angina

21 (51.2)

5 (17.2)

0.008*

 Coronary artery disease

10 (24.4)

3 (10.3)

0.239

 LVEF (%)

63 ± 12

60 ± 14

0.839

  1. Age (years) described in mean and standard deviation, t test. Other variables described by percentage (%), Chi square test. The control subjects (n = 9) had a mean age of 35 ± 15 years, which 22% were male and did not manifest the risk factors mentioned
  2. IHD ischemic heart disease, VHD valvular heart disease, LVEF left ventricular ejection fraction